Browse By: Country ι Category ι Latest Reports ι Tag

Biosimulation Market - Global Scenario, Trends, Industry Analysis, Size, Share And Forecast, 2011 - 2018

View Report Details
Description

Biosimulation is computer aided mathematical simulation of biological systems and processes. Biosimulation is used for model based calculation of biological systems. The global biosimulation market is expected to grow at a considerable rate from 2011 to 2018.The primary reason for the growth of biosimulation is the increasing use of pharmacodynamic and pharmacokinetic (PKPD) modeling in pre-clinical drug development. PKPD is the most widely used method in drug development.  Increasing importance of advanced techniques to reduce the drug development and discovery cost is the primary factor for the growth of the global biosimulation market. Also, increased spending on health care, adva... Click here for more details


Sales Force Effectiveness in Pharmaceuticals - Cost Pressures Increase Pharmaceutical Companies Adoption of New Sales Models and Technologies
GBI Research’s report, “Sales Force  Effectiveness in Pharmaceuticals - Cost Pressures Increases Pharmaceutical Companies\' Adoption of New Sales Models and Technologies”, provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes t
Published Date: Oct 2010
Price: $3500
Contract Manufacturing Organizations (CMO) in Eastern Europe - Inconsistent Demand and Competition from Asia Raises Concerns
GBI Research, the leading business intelligence provider, has released its latest report, “Contract Manufacturing Organizations (CMO) in Eastern Europe - Inconsistent Demand and Competition from Asia Raises Concerns” that provides key data, information and analysis of the major tre
Published Date: Oct 2010
Price: $3500
Pharmaceutical Analytical Services Outsourcing in India: Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers
GBI Research’s medical devices report, “Pharmaceutical Analytical Services Outsourcing in India: Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers” provides key data, information and analysis on the pharmaceutical analytical services outsourcing in in
Published Date: Nov 2010
Price: $3500
Patent Strategies - Effective Strategies for Extension of Product Lifecycles and Combating Aggressive Generics Markets
GBI Research’s new report, “Patent Strategies - Effective Strategies for Extension of Product Lifecycles and Combating Aggressive Generics Markets”, provides in-depth analysis of various patent protection strategies adopted by pharmaceutical companies for maximizing revenues re
Published Date: Dec 2010
Price: $3500
Antihypertensives Market to 2016 - Generic Erosion Following Patent Expiry of Major ARBs to Impact the Market
GBI Research, a leading business intelligence provider, has released its latest research, “Antihypertensives Market to 2016 - Generic Erosion Following Patent Expiry of Major ARBs to Impact the Market”. The report provides in-depth analysis of the unmet needs, drivers and barriers
Published Date: Dec 2010
Price: $3500
Emerging Markets for Clinical Trials in India - Favorable Regulatory Environment and Cost Effectiveness Will Accelerate the Number of Clinical Trials
GBI Researchs new report, Emerging Markets for Clinical Trials in India - Favorable Regulatory Environment and Cost Effectiveness Will Accelerate the Number of Clinical Trials, provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes the effective strategie
Published Date: Jan 2011
Price: $3500
Emerging Market for Clinical Trials in China - Communication Problems and Unresolved Intellectual Property Issues Restrict Growth
GBI Research has released its pharmaceutical report, Emerging Market for Clinical Trials in China - Communication Problems and Unresolved Intellectual Property Issues Restrict Growth that provides key data, information and analysis of the major trends and issues affecting the clinical trial market
Published Date: Apr 2011
Price: $3500
Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market
GBI Research, the leading business intelligence provider, has released its latest research Sleep Disorders Market to 2017- Generics Substitution Coupled with a Weak Pipeline Will Negatively Impact the Market, which provides insights into sleep disorders therapeutics sales and price forecasts u
Published Date: Apr 2011
Price: $3500
Clinical Trial Recruitment Strategies in Oncology - Online Recruitment Methods and Use of IT - enabled Patient Management Systems will Reduce Recruitment Time and Cost
GBI Research has released its research, Clinical Trial Recruitment Strategies in Oncology - Online Recruitment Methods and Use of IT - enabled Patient Management Systems will Reduce Recruitment Time and Cost, which provides insights into recruitment strategies, challenges and solutions for on-
Published Date: May 2011
Price: $3500
ENT Disorders Market to 2016 - Increasing Resistance to Anti-Bacterials to Drive Development of Novel Therapies for ENT Disorders
GBI Researchs pharmaceutical report, ENT Disorders Market to 2016 - Increasing Resistance to Anti-Bacterials to Drive Development of Novel Therapies for ENT Disorders provides in-depth analysis of unmet needs, drivers and barriers that impact the global ENT disorders market. The report ana
Published Date: Apr 2011
Price: $3500

 


 

Related News

China Denies Encroachment of South China Sea Ahead of ASEAN Meeting
Ahead of the approaching ASEAN meeting, Chinese officials are trying to negate accusations regarding aggression in the South China Sea. In the last couple of months, the Chinese government has received severe criticism for construction projects in the South China Sea. Japan and Philippines, which are some of the regional powers in the region are worried these construction projects reflect a regenerated imperialist outlook in the communist nation. Leaders from other regional powers fear tha
Date: Aug 04

Japan Temporarily Stops Construction of U.S. Base
Japan recently announced that it was temporarily stopping construction of a disputed U.S. air base on Okinawa Island for almost a month to conduct talks between the central government and the island authorities that are opposing the facility. The residents of Okinawa, which is the site of the bloody war between the Japanese and the U.S forces towards the end of the second world war, have long raised objection for presence of tens of thousands of U.S. forces and U.S. military fixtures on 18% o
Date: Aug 04

China doubles its Efforts into the Solar Energy Sector
The trend of countries pledging to cut down their carbon emissions has been growing strong in the West, however, several countries in the East are also showing commitment to reducing their carbon footprint. Furthermore, China known for its substantial carbon footprint has pledged to reduce its carbon emissions by a great degree in the coming few years. This initiative by China has been applauded by several countries around the world such as France. Recent figures show that China has increased
Date: Aug 04

Butterfly Stance Inspiring Solar Panel Designs
Bio mimicry has been used by engineers and scientists around the world to develop many ground breaking designs. Recently, engineers from the University of Exeter are exploring the ways to mimic the stance of the Cabbage White butterfly in their solar panels design. It is expected that these panels inspired from the butterfly stance will boost the efficiency by around 50 per cent. The design inspired by the Cabbage White butterfly is actually a common sight in Europe during the summer days. Ho
Date: Aug 04

Tyson Foods’ Hit by Rising Cost of Beef, Reports 10% Decline in Q3
One of the biggest processors of beef, pork, and chicken, Tyson foods reported on Aug 03, 2015, that the soaring cost of cattle has led to a fall of US$84 million in the business of the company in the Q3 of this fiscal year. The company also stated that if the beef market does not improves very soon, the company is afraid that it will not meet its earnings projection for this full-year. Tyson registered a revenue amounting to US$10.07 billion in Q3, citing an increase of 4% comparing to 2014.
Date: Aug 04

ALEC Defends Deal between Australia and China over Live Cattle Exports
The recent deal of Australia with China over the live cattle exports has been defended by the Australian Livestock Exporters’ Council (ALEC) after the RSPCA criticized the deal on Aug 03, 2015. Australia and China have signed an agreement over the feeder and butchery cattle health protocol in July, which was expected to help in opening up exceptional access for live cattle exports from Australia to China. In a statement the CEO of RSPCA Australia, Mr. Heather Neil stated that exporting
Date: Aug 04

Oil Prices Rise with Gains in China Stock Market
Global prices of crude on Tuesday went up from multi-month lows, backed by a rally in the stock market in China, the second largest oil consumer in the world. However, traders and analysts said that a weak demand outlook and abundant supply are unlikely to hold on to the crude rebound.  Global benchmark for oil Brent as well as U.S. crude settled at a higher level for the first time in four sessions. This was reported a day after the 5 per cent rout triggered on Monday by China’s w
Date: Aug 04

Spending Cuts by Oil Companies Likely in Exploration and Drilling
Some of the largest oil companies in the world have promised to reduce their costs of larger projects amid slipping oil prices. However, with crude priced below US$ 50 per barrel, the unrelenting price weakness indicates that these companies will have to dig much deeper to recover.  Over the past year, prices of oil dropped a massive 60 per cent from a high of US$ 114 per barrel in 2014. Amidst this, energy giant in the United Kingdom BP PLC started experimenting with new projects aimed
Date: Aug 04

Upfront Payout of US$65 Million for Isis Pharma
Isis Pharmaceuticals continues to expand into multiple disease sectors, in which the latest move includes the signing of a top level drug development partnership with another drug company. The new partnership with AstraZeneca will get US$65 million to Carlsbad biotech upfront. The deal also calls for Isis Pharma to discover and work on drugs that are useful in cardiovascular, kidney, and metabolic diseases. They are to develop these drugs using the antisense technology developed by Isis. I
Date: Aug 03

16.59% Rally of China Pharma Holdings’ Shares
China Pharma Holdings, Inc. company shares rose by 16.59% in the previous week. The pharma company still tallied to a loss of 23.53% during the past four weeks. The company share did surpass the S&P 500 in the previous week by 15.25%. However, they have underperformed the index by 24.51% within the last four weeks. China Pharma Holdings, Inc. shares have slowed down by 29.73% within the previous three month period. The current year-on-year performance is -13.36%. The company shares
Date: Aug 03

Upcoming Reports

Acute Myeloid Leukemia (AML) Therapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
Acute myeloid leukemia grows at a fast pace and is found in the blood and bone marrow. The leukemia therapeutics market is divided into four segments namely acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia and chronic myeloid leukemia. In the disease process, imma
Published By: Transparency
Price: $4795
Antibiotic Market - Global Industry Size, Share, Trends, Analysis And Forecast, 2012 - 2018
An antibiotic is a compound or a substance that fights bacterial infections and kills or slow down their growth. The antibiotic market is witnessing high growth due new product innovations and higher investment in R & D activity. Moreover, the other regulatory concerns to control the antibioti
Published By: Transparency
Price: $4795
Next Generation Sequencers Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Next generation sequencers are used inthe sequencing technologies which massively parallelize the DNA sequencing process rather than being limited to single or few fragments of DNA. The next generation sequencing (NGS) technology enables rapid sequencing and produce thousands and millions of seque
Published By: Transparency
Price: $4795
Rheumatoid Arthritis Pharmacotherapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Treatment options for rheumatoid arthritis (RA) are expanding as a result of increasing research activities and more explicit understanding of the pathophysiology of diseases. For the treatment of RA, novel selective inhibitors such as cyclooxygenase-2 (COX-2) are used along with the non-steroidal
Published By: Transparency
Price: $4795
Prenatal Diagnostics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Prenatal diagnostics is a procedure for testing of diseases before the birth of a child, to determine certain inheritable disorders such as chromosome abnormalities, Down’s syndrome, genetic diseases, neural tube defects, and other conditions. It can be conducted by various procedures of scr
Published By: Transparency
Price: $4795
Pediatric Vaccines Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global pediatric vaccine market is forecasted to reach $24.3 billion by the year 2017 at a compounded annual growth rate of 11.5 % during 2011-2017. This growth in revenues is expected to be driven by the introduction of new molecules that are currently in regulatory filing stage and those i
Published By: Transparency
Price: $4795
Dermatological Diagnostics And Therapeutics Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The Dermatological diagnostics and therapeutics market is expected to grow steadily during the forecast period driven by increase in psoriasis market that is expected to boost competition among the existing products with more emerging therapies. Acne is the largest market segment of the dermatolog
Published By: Transparency
Price: $4795
Hepatitis C Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The world market for HCV drugs represents an area of potential opportunities in developed as well as developing countries. Because of the technological advancements and effectiveness, many big market players are focusing on development of innovative drugs for HCV. Major companies are forming coali
Published By: Transparency
Price: $4795
EPharmacies Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
The global market for ePharmacies is projected to reach USD 51.75 billion by the end of 2017 owing to the increasing number of tech-savvy people and rising demand for prescription drugs. The ePharmacies meeting the regulatory standards set by the government and following ethical business practices
Published By: Transparency
Price: $4795
Congestive Heart Failure Treatment Devices Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The global market for congestive heart failure treatment devices is expected to reach $5.9 billion by the year 2016 at the compounded annual growth rate of 11.7% during the forecasted period. This growth is mainly attributed by the rising incidences of heart failures across the world. American mar
Published By: Transparency
Price: $4795